论文部分内容阅读
目的对56例房颤患者接受抗凝治疗进行随访观察。方法选取我院近年接诊的56例患者进行随访,对其服药方法、指标监测进行观察,并详细登记INR数值变化,对患者病症和各项情况记录分析。结果患者接受抗凝治疗后多数好转,治疗用药剂量要根据实际随时调整,有不良反应发生及时就诊。结论房颤致死率、致残率较高,华法林抗凝剂治疗可以有效降低这一风险,在临床上具有较大价值。
Objective To observe the clinical data of 56 patients with atrial fibrillation receiving anticoagulant therapy. Methods Fifty-six patients admitted to our hospital in recent years were followed up, their medication method and index monitoring were observed, and the change of INR value was registered in detail, and the patient’s illness and various conditions were recorded and analyzed. Results Most patients received anticoagulant therapy improved, the dose of treatment based on actual adjustment at any time, adverse reactions occur in time for treatment. Conclusion Atrial fibrillation mortality and disability rate higher, warfarin anticoagulant therapy can effectively reduce the risk in the clinical has great value.